雷公藤制剂安全性的循证评价研究Evidence-based evaluation on safety of Tripterygium wilfordii preparations
冯雪;方赛男;高雨鑫;刘建平;陈薇;
FENG Xue;FANG Sai-nan;GAO Yu-xin;LIU Jian-ping;CHEN Wei;Centre for Evidence-Based Chinese Medicine,Beijing University of Chinese Medicine;Department of Sociology,Acadia University;
摘要(Abstract):
该研究旨在通过结合文献计量学研究和循证评价研究的方法,对雷公藤Tripterygium wilfordii(TW)制剂的安全性进行循证评价,为政府决策和临床应用提供TW制剂(肾毒性)的循证安全性信息,为今后中草药肾毒性评估提供方法和建议。通过系统搜索国内外相关数据库,全面搜索CNKI,SinoMed,VIP,万方,PubMed,Cochrane图书馆等6个中英文数据库,检索文献类型为TW制剂安全性的所有研究类型文献,并根据纳入和排除标准对文献进行筛选和提取。所有纳入研究的方法学质量均由国际公认的评估工具或标准进行评估,用R软件分析发病率,并根据干预类型,给药途径,用药时间和研究类型进行亚组分析。
The study was aimed to conduct an evidence-based evaluation on the safety of Tripterygium wilfordii( TW) preparations through a method combined bibliometrics research with evidence-based evaluation research,to provide evidence-based safety information of the TW preparations( nephrotoxicity) for the government decision-making and clinical application,and to provides methods and suggestions for evaluating nephrotoxicity of Chinese herbal medicine( CHM) in the future. We searched relevant databases at home and abroad systematically,and six Chinese and English databases including CNKI,Sino Med,VIP,Wan Fang,Pub Med,and Cochrane library were comprehensively searched. All types of research documents about the safety of TW preparations. Literature were screened and extracted based on inclusion and exclusion criteria. The methodology quality of all included studies were assessed by internationally recognized evaluation tools or standards. The incidence rate was analyzed by using R software. Subgroup analysis were conducted according to the type of disease treated,drug delivery way,medication time,and study types.
关键词(KeyWords):
循证评价;安全性;雷公藤
evidence-based evalutation;safety;Tripterygium wilfordii
基金项目(Foundation): 国家自然科学基金青年基金项目(81603451)
作者(Authors):
冯雪;方赛男;高雨鑫;刘建平;陈薇;
FENG Xue;FANG Sai-nan;GAO Yu-xin;LIU Jian-ping;CHEN Wei;Centre for Evidence-Based Chinese Medicine,Beijing University of Chinese Medicine;Department of Sociology,Acadia University;
DOI: 10.19540/j.cnki.cjcmm.2018.0010
参考文献(References):
- [1]Chou W C,Wu C C,Yang P C,et al.Hypovolemic shock and mortality after ingestion of Tripterygium wilfordii hook F.:a case report[J].Int J Cardiol,1995,49(2):173.
- [2]Li X X,Du F Y,Liu H X,et al.Investigation of the active components in Tripterygium wilfordii leading to its acute hepatotoxicty and nephrotoxicity[J].J Ethnopharmacol,2015,162:238.
- [3]国家食品药品监督管理局.关注雷公藤制剂的用药安全[J].药品不良反应信息通报,2012(46):1.
- [4]Higgins J P T.Green S.Cochrane handbook for systematic reviews of interventions.Version 5.1.0.[EB/OL].(2008-09-22)[2017-11-21].http://handbook.cochrane.org/.
- [5]Higgins J P T,Green S.Chapter 14:Adverse effects.Cochrane handbook for systematic reviews of interventions.Version 5.1.0.[EB/OL].(2008-09-22)[2017-11-21].http://handbook.cochrane.org/.
- [6]曹珊,陈清萍.雷公藤多苷片联合缬沙坦治疗Ig A肾病蛋白尿的疗效[J].实用临床医学,2012,13(11):9.
- [7]刘劲松,周琳,荣光辉.肾复康治疗原发性膜性肾病的临床研究[J].中国医药指南,2016,14(04):187.
- [8]孙建平,高延霞,李琳.正清风痛宁片治疗中老年慢性肾炎临床疗效观察[J].中国老年学杂志,2007,27(22):2234.
- [9]孙建平,高延霞,董晖.青藤碱制剂治疗慢性肾小球肾炎28例临床观察[J].临床荟萃,2007,22(16):1194.
- [10]汪翠.中药加雷公藤多苷片治疗特发性膜性肾病疗效观察[D].武汉:湖北中医药大学,2015.
- [11]达其伟,唐景晖,尚可儒,等.黄芪桂枝五物汤加减内服、熏蒸联合西药治疗类风湿关节炎30例[J].中医研究,2015,28(9):10.
- [12]沈杰,张之澧.雷公藤多苷合小剂量甲氨蝶呤治疗老年性类风湿性关节炎[J].浙江中西医结合杂志,2002,12(6):334.
- [13]郭立芳.祛风清热化瘀通络煎剂治疗类风湿性关节炎的临床研究[D].石家庄:河北医科大学,2007.
- [14]黄飞霞.理肠汤、雷公藤多苷片口服和溃疡灵灌肠治疗活动期溃疡性结肠炎的临床观察[D].广州:广州中医药大学,2011.
- [15]黄小玲,黄丽雅.雷公藤总内酯片治疗类风湿性关节炎的临床观察[J].广东药学院学报,2002,18(3):237.
- [16]罗国良,陈用军,石年.消银汤治疗寻常型进展期银屑病临床疗效观察[J].中国现代医生,2011,49(2):43.
- [17]沈瑞子,邱仁斌,邓惠文.青风藤汤治疗类风湿性关节炎45例疗效观察[J].新中医,2004,36(9):26.
- [18]唐若余,宋卫珍.来氟米特、雷公藤多苷联合滋阴补血方治疗系统性红斑狼疮的疗效观察[J].中外医学研究,2014,12(35):99.
- [19]张剑勇,谢静静,高建华,等.昆仙胶囊联合中药辨证治疗类风湿关节炎的疗效评价[J].风湿病与关节炎,2012,1(6):14.
- [20]章可谓.中药内服外贴联合西药治疗类风湿关节炎49例[J].中医药学报,2008,12(6):59.
- [21]周德荣.搜骨清血法治疗类风湿性关节炎临床疗效观察[J].中国中医药信息杂志,2005,12(6):68.
- [22]周艳,韩丹,牟宽厚,等.阿维A联合雷公藤及他卡西醇软膏治疗中重度银屑病的临床疗效[J].山西医科大学学报,2015,46(6):579.
- [23]国同河.甲氨蝶呤和来氟米特及雷公藤多苷片小剂量联合应用、治疗类风湿性关节炎的临床观察[J].中华现代内科学杂志,2009,6(2):96.
- [24]徐丽华.甲氨蝶呤联合来氟米特及雷公藤多苷治疗类风湿关节炎65例临床观察[J].医学信息,2010,23(11):64.
- [25]谢宝官,钟文,蒙姝丽.雷公藤多苷片副作用的临床观察[J].广西医学,2002,24(4):576.
- [26]赵叶.182例雷公藤多苷片不良反应分析及预防措施[J].山东中医杂志,2012,31(8):572.
- [27]郑洁.昆仙胶囊治疗慢性肾小球疾病的安全性研究[D].广州:广州中医药大学,2013.
- [28]朱春来,罗观.甲氨蝶呤和硫酸软骨素联合雷公藤小剂量治疗类风湿关节炎临床疗效观察[J].中国社区医师:医学专业,2012,14(12):135.
- [29]蔡长春.口服过量雷公藤多苷片致肾功能衰竭1例[J].临床误诊误治,1994,7(4):174.
- [30]关继华.服雷公藤片过量死亡1例[J].新疆中医药,1992(4):21.
- [31]关黎红,付尔康.小儿误服雷公藤多苷片引起中毒1例[J].西北药学杂志,1996,11(6):256.
- [32]何满仓,李小斌,张跃,等.雷公藤制剂致肝肾损害3例[J].药物不良反应杂志,2006,8(2):136.
- [33]胡成文.雷公藤急性中毒致死一例[J].安徽医学,1995,16(6):10.
- [34]黄河清,程坚.口服大剂量雷公藤多苷片致急性肾功能衰竭死亡1例报告[J].河南医药信息,1996,4(6):41.
- [35]陆钫,张德星,田树敏.雷公藤多苷中毒引起急性肾衰一例[J].上海医学,1996,19(5):268.
- [36]宁旺榕.昆明山海棠片引起不良反应1例[J].中草药,1998,29(12):823.
- [37]潘全梅.服用过量雷公藤多苷片致中毒1例护理体会[J].实用护理杂志,1996,12(1):36.
- [38]史影,王梅.雷公藤中毒致急性肾功能衰竭1例[J].中国实用内科杂志,1999,19(8):54.
- [39]王世茹,段群录.雷公藤多苷致急性肾功能衰竭及粒细胞缺乏死亡1例[J].河北医药,1996,18(3):196.
- [40]王淑芬,刘玉春,王海燕,等.雷公藤肾毒性的临床观察[J].中国中药杂志,1996,21(1):52.
- [41]徐智健.大剂量雷公藤总苷中毒致死1例[J].福建医药杂志,1991(2):2.
- [42]殷操,梁敏,王炫.曲安缩松和/或雷公藤治疗口腔扁平苔藓110例疗效分析[J].广东牙病防治,1996,4(1):18.
- [43]李原丽,覃筱芸.雷公藤294例不良反应的文献调查与分析[J].山西医药杂志,2011,40(1):88.
- [44]莫梅英,冷扬.泼尼松长期应用的不良反应及合理应用[J].现代中西医结合杂志,2007,16(18):2588.
- [45]Tuffaha H,Alomar S.Glucarpidase rescue in a patient with highdose methotrexate-induced nephrotoxicity[J].J Oncol Pharm Pract,2011,2(17):136.
- [46]熊秀莲.柳氮磺吡啶致血尿一例[J].中华风湿病学杂志,2000,4(2):96.
- [47]葛红星,李庆,雷招宝.正清风痛宁的不良反应与合理用药建议[J].中成药,2010,32(2):287.
- [48]江云鸥,陈倩岚,张志勇.雷公藤多苷片不良反应的回顾性分析[J].华西医学,2009,24(9):2357.
- [49]Torgerson D,Roberts C.Randomisation methods:concealment[J].BMJ,1999,319(7206):375.
- [50]Liu J,Kjaergard L L,Gluud C.Misuse of randomization:a review of Chinese randomized trials of herbal medicines for chronic hepatitis B[J].Am J Chin Med,2002,30(1):173.
- [51]王觉生,康德英.卫生系统重大科研课题终审标书在设计方面的共性问题[J].中国临床康复,2003,7(3):353.
- [52]Schulz K F.Assessing allocation concealment and blinding in randomized controlled trials:why bother?[J].ACP J Club,2000,132(2):A11.
- [53]于河,杨红,刘建平.专家临证验案与经验的报告方法——病例系列研究的设计和质量评价[J].中医杂志,2008,49(5):407.
- [54]费宇彤,杨红,刘兆兰,等.药品不良反应个案报道的规范性报告[J].中国药物警戒,2010,7(4):206.
- 冯雪
- 方赛男
- 高雨鑫
- 刘建平
- 陈薇
FENG Xue- FANG Sai-nan
- GAO Yu-xin
- LIU Jian-ping
- CHEN Wei
- Centre for Evidence-Based Chinese Medicine
- Beijing University of Chinese Medicine
- Department of Sociology
- Acadia University
- 冯雪
- 方赛男
- 高雨鑫
- 刘建平
- 陈薇
FENG Xue- FANG Sai-nan
- GAO Yu-xin
- LIU Jian-ping
- CHEN Wei
- Centre for Evidence-Based Chinese Medicine
- Beijing University of Chinese Medicine
- Department of Sociology
- Acadia University